News

Special Sections

Q BioMed Partners with SRI to Develop Pediatric Developmental Nonverbal Disorder Therapy

Q BioMed Partners with SRI to Develop Pediatric Developmental Nonverbal Disorder Therapy

Edward Kim | Equities.com |

Part of Q BioMed's autistic spectrum disorder drug development program (Image: Autism Speaks)


BioLineRx Begins Triple Combination Arm of Phase 2a Pancreatic Cancer Trial

Edward Kim | Equities.com |

BL-8040 + Keytruda + chemotherapy combination in metastatic pancreatic cancer (Image: BioLineRx)


CollPlant Announces Positive Clinical Data Published for Tennis Elbow Treatment

Edward Kim | Equities.com |

59% improvement in chronic tennis elbow at 6 months after treatment with recombinant human collagen for soft tissue repair.


Is Your Financial Data Leaking Through Your Smartphone?

Desireé Duffy | Equities.com |

Cell phone wouldn’t be much use without the internet or apps. The question is, how safe is your data?


DiaMedica Therapeutics Raises $16 Million and Uplists to Nasdaq

Edward Kim | Equities.com |

Lead compound targeting acute ischemic stroke and chronic kidney disease (Image: DiaMedica Therapeutics).


Premier Biomedical Expands Distribution Network for CBD / Hemp Oil Pain Relievers

Edward Kim | Equities.com |

Keep an eye on the 2018 Farm Bill, which may get a vote in Congress next week.


OPEC Hopes Lead to Oil Rally for Second-Straight Session, Gold Extends Gains

Jacob Maslow | Equities.com |

Stock futures fell to start the day after the White House and Donald Trump’s statement on a trade deal with China didn’t match.


Giyani Metals: High Grade Manganese Opportunity for Lithium Ion Batteries

Edward Kim | Equities.com |

Lithium ion battery market estimated to grow to over $100 billion by 2025 driven by increasing electric vehicle demand.


​Biotech in 2019: Gene Therapies, Cancer Immunotherapies, and mRNA

Guild Investment Management | Equities.com |

Investing in early-stage biotechnology companies requires great skill and patience (luck is always helpful as well).


PetVivo: Microcap Play in $18 Billion Veterinary Care Market

Edward Kim | Equities.com |

Lead product for osteoarthritis in dogs and lameness from navicular disease in horses (Image: PetVivo).


Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Events

The MoneyShow Orlando

Attend the largest gathering of Wall Street's most experienced and insightful experts in Orlando this winter and get the best investing and trading education money can buy—for FREE!

Learn more